Osteoarthritis, Shoulder

11

Review clinical trials related to Osteoarthritis, Shoulder. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Diaphragm-Sparing Regional Anesthesia Techniques for Shoulder Surgery

This study will compare two regional anesthesia techniques for shoulder surgery and evaluate their effects on diaphragmatic function. The standard regional anesthesia technique for shoulder surgery is the interscalene brachial plexus block (ISB), which provides effective analgesia but is frequently associated with ipsilateral hemidiaphragmatic paresis due to phrenic nerve involvement. An alternative diaphragm-sparing strategy is the combination of a suprascapular nerve block (SSNB) and an infraclavicular brachial plexus block (ICB), which may reduce the risk of diaphragmatic dysfunction while maintaining effective analgesia for shoulder surgery. All participants will receive ultrasound-guided regional anesthesia prior to surgery and will be randomly assigned to one of two groups: Group 1: Interscalene brachial plexus block Group 2: Suprascapular nerve block combined with infraclavicular brachial plexus block The primary aim of this study is to determine whether the diaphragm-sparing technique reduces the incidence of hemidiaphragmatic paresis while providing analgesia comparable to the standard interscalene block. Diaphragmatic movement will be assessed using ultrasound before and after block placement. Secondary outcomes include postoperative pain intensity, opioid consumption, pulmonary function parameters, and block-related complications.

Participants needed: 70
Trial details
Age: 65-100Biological sex: AllType: InterventionalSponsor: Poznan University of Medical SciencesUpdated: May 22, 2026Locations: 1
Eligibility criteria

Age ≥ 65 years [+4]

Allergy to local anesthetics [+7]

Status: Recruiting

Perform Humeral System Study

This study is an international, single arm, multicenter, prospective, non-significant risk, Post-Market Clinical Follow-up study, which is designed to collect safety and performance data at baseline, surgery, immediate post-op and annually through 10 years post-operation. Data collected from this study will be used for purposes, including but not limited to, Post-Market Surveillance, peer-reviewed publications, education materials, regulatory submissions, and/or product development.

Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Stryker Trauma and ExtremitiesUpdated: Feb 20, 2026Locations: 10
Eligibility criteria

18 years or older at the time of the informed consent or non-opposition (when ap... [+4]

Not able to comply with the study procedures based on the judgment of the assess... [+10]

Status: Recruiting

FX Shoulder Prospective Clinical Study

Prospective Multi-Center Registry on study subjects with implanted devices marketed and legally commercialized in the USA by FX Shoulder Solutions.

Participants needed: 600
Trial details
Biological sex: AllType: ObservationalSponsor: FX Shoulder SolutionsUpdated: Feb 9, 2026Locations: 4Duration: 10 Years
Eligibility criteria

Not listed

Status: Recruiting

The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis

This is a non-surgical trial comparing the clinical and functional outcomes of patients with osteoarthritis treated with Intra-articular injection of Micro Fragmented Adipose Tissue versus conventional therapy of intra-articular injection of corticosteroid.

Participants needed: 48
Trial details
Phase: Phase 1Age: 25-75Biological sex: AllType: InterventionalSponsor: Stanford UniversityUpdated: Oct 30, 2025Locations: 1
Eligibility criteria

Age between 25 and 75 years-old [+7]

Age < 25 or > 75 years old [+15]

Status: Recruiting

Prophylactic Conjoint Tendon Lengthening During Reverse Shoulder Arthroplasty Outcomes

Some patients may experience persistent pain in the front of their shoulder after reverse shoulder replacement. One of the possible reasons for this is that the surgery causes a change in the alignment of the shoulder joint, which may cause increased tension and compression on one of the biceps tendon called the conjoint tendon. The purpose of this study is to evaluate whether conjoint tendon lengthening, a surgical procedure that involves cutting and lengthening the conjoint tendon in order to reduce tension and compression, is able to prevent or reduce the risk of anterior shoulder pain at one year after surgery.

Participants needed: 110
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Nickolas GarbisUpdated: Mar 7, 2025Locations: 1
Eligibility criteria

Patients who are at least 18 years old undergoing primary reverse total shoulder... [+1]

Patients younger than 18 years old [+3]

Status: Not yet recruiting

DenCT Shoulder Bone Quality Evaluation

The objective of the study is to evaluate the preoperative bone quality assessment based on CT to later establish a scale for the decision of stemless shoulder arthroplasty.

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Zimmer BiometUpdated: Feb 10, 2025Locations: 1
Eligibility criteria

Patient must be older than 18 years and skeletally mature. [+10]

Fractures of the proximal humerus, where other methods of treatment are deemed i... [+9]

Status: Recruiting

Embo Registry; National Registry for Artery Embolization

Embo Registry is a retrospective and prospective observational study to evaluate real world effectiveness and the use of Artery Embolization as a treatment for chronic pain with patients that have osteoarthritis and localized pain to provide symptomatic relief. This study is to determine the efficacy and validity of procedure and that following procedure patients had decreased pain and improved quality of life.

Participants needed: 1,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Vascular Solutions of North CarolinaUpdated: Oct 28, 2024Locations: 2Duration: 12 Months
Eligibility criteria

> 18 years of age undergone artery embolization interventions for the treatment...

None

Status: Recruiting

TSA v RSA in Osteoarthritic Shoulders With Greater Than 15 Degrees of Retroversion

This study will compare total shoulder arthroplasty (TSA) with an augmented glenoid component and reverse shoulder arthroplasty (RSA) procedures, in participants with advanced glenohumeral osteoarthritis aged 65 years and older, who also present with greater than 15 degrees of glenoid retroversion, in the context of a prospective, randomized controlled trial to determine the optimal treatment in this patient population.

Participants needed: 108
Trial details
Age: 65+Biological sex: AllType: InterventionalSponsor: Ottawa Hospital Research InstituteUpdated: Apr 30, 2024Locations: 1
Eligibility criteria

Diagnosis of idiopathic shoulder OA. [+4]

Active joint or systemic infection [+11]

Status: Recruiting

TSA Techniques in Glenohumeral OA

Osteoarthritis (OA) of the shoulder is a disease resulting from the wearing down of cartilage over time. OA can produce pain and dysfunction at the affected joint and is a growing occurrence in an aging population. Total shoulder arthroplasty (TSA) is a surgical treatment used to treat patients with shoulder OA which involves replacing the worn-out ball and socket shoulder joint with prosthetic components. TSA is performed today with high success rates, however, complication rates associated with TSA remain prevalent particularly when the arthritis is associated with bone erosion on the glenoid (socket). Given the high rate of revisions associated with TSA treatment in the setting of glenoid bone erosion, a number of surgical strategies have been developed. These surgical techniques include eccentric reaming which involves removing bone from the front of the socket, augmented glenoid component implantation, and posterior bone grafting to compensate for glenoid bone loss, and reverse shoulder arthroplasty. Few research studies have compared these different surgical techniques to one another. Previous studies have been limited to case series with small sample sizes and respective designs. This study is being conducted to determine which approach produces better outcomes. For the purpose of this study we will be comparing total shoulder arthroplasty techniques a) augmented glenoid component and eccentric reaming and b) augmented glenoid component and bone grafting in participants with advanced glenohumeral osteoarthritis.

Participants needed: 216
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Ottawa Hospital Research InstituteUpdated: Apr 30, 2024Locations: 1
Eligibility criteria

The use of drugs including analgesics and non-steroidal anti-inflammatory drugs [+5]

< 10 degrees / > 27 degrees of glenoid retroversion [+12]

Status: Recruiting

FX Shoulder Solutions Retrospective / Prospective Clinical Study

Subjects implanted with the shoulder replacement medical devices manufactured by FX Shoulder Solutions and distributed by FX Shoulder Solutions.

Participants needed: 600
Trial details
Biological sex: AllType: ObservationalSponsor: FX Shoulder SolutionsUpdated: Oct 12, 2023Locations: 2
Eligibility criteria

Received an FX Shoulder Solutions replacement medical device in accordance with...

Patient who does not meet the inclusion criteria above

Status: Not yet recruiting

Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis

This is a phase 2 open-label, 6 arms (1 study group and 1 control group for each joint category), randomized control group clinical study with 300 subjects diagnosed with osteoarthritis of knees (n=100), hips (n=100) and shoulders (n=100). The study subjects will be evaluated for disease-associated severity according to symptoms, such as pain, mobility, daily active life, and functions using arthritis society established specific measurement tools related to the joints (KOOS and KSS for OA-knees: HOOS and HHS for OA-hips and ASES and CSS for OA-shoulders).

Participants needed: 300
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Celltex Therapeutics CorporationUpdated: Apr 18, 2023Locations: 1
Eligibility criteria

Age above 18 years [+4]

Participation in another clinical study (with use of another Investigational Med... [+15]